GlassScriptPrepare for your visit
Nirav P Chiniwalla
Gastroenterology (Internal Medicine) · Concord, NC · NPI 1114955291
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$11,962.34
in general payments reported to CMS, 2019-2025 · $2,829 in 2025
The $2,829 reported for 2025 was more than what 86% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Who reported paying
General payments only, top 6 by amount.
- Abbvie INC. $2,198.49
- Salix Pharmaceuticals, A Division of Bausch Health US, LLC $1,207.44
- Janssen Biotech, INC. $1,197.32
- Gilead Sciences, INC. $1,161.06
- Takeda Pharmaceuticals U.S.A., INC. $850.49
- Boston Scientific Corporation $683.59
Drugs and devices associated with these payments
Skyrizi Rinvoq Tremfya Dupixent General - Biliary Devices Entyvio Linzess Xifaxan Givlaari Zenpep Creon Stelara
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Nirav Chiniwalla listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/594159/nirav-p-chiniwalla